Korea MFDS Introduces New Self-Testing IVD Categories for Influenza and Drugs of Abuse

The Ministry of Food and Drug Safety (MFDS) amended the Regulation on IVD Medical Device Items and Item Classification (Notification No. 2026-45) on June 30, 2026, establishing two new categories of self-testing in vitro diagnostic medical devices (IVDs) for influenza and drugs of abuse.



The amendment expands public access to self-testing IVDs by broadening the scope beyond the existing nine self-testing IVD categories, including those for pregnancy, blood glucose, and COVID-19. The newly introduced influenza self-test kit is expected to enable rapid identification of infected individuals during the early stages of infection, helping to reduce disease transmission. In addition, the drugs of abuse self-test kit will allow individuals to quickly determine whether they have been unintentionally exposed to illicit drugs, supporting timely and appropriate responses.

 
The newly established self-testing IVD categories are as follows.

K05070.01 IVD reagents for self testing of Influenza virus or SARS-CoV-2 using immunological method (Class 3) - Effective June 30, 2026

K06060.01 IVD reagents for self testing of drugs of abuse (Class 2) - Effective June 30, 2028


GCA Korea provides expert support for global companies navigating Korea’s regulatory requirements, including KC Certification.

Contact
Tel. +82-31-360-8180
E-mail: forest.lee@gca-kr.com


Unauthorized reproduction, citation, or use of this content is prohibited. The source and link must be clearly stated.

Comments

Popular posts from this blog

Upcoming Changes to Child Car Seat Safety Standards in Korea

KC Certification Requirements for Vehicle Keyfobs in Korea

South Korea Mandates Fire Extinguishers in All Vehicles with Five or More Seats